Evidence map›Paper›PMID 37444619›Full record

ReviewCancers2023

Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition.

Bianca Medici, Beatrice Riccò, Eugenia Caffari, Silvia Zaniboni, Massimiliano Salati, Andrea Spallanzani, Ingrid Garajovà, Stefania Benatti, Chiara Chiavelli, Massimo Dominici and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Real-world characteristics and outcomes of patients with BRAFESMO real world data and digital oncology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Bianca MediciDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Beatrice RiccòDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.ORCID 0000-0001-6006-3589
Eugenia CaffariDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Silvia ZaniboniDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Massimiliano SalatiDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Andrea SpallanzaniDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.ORCID 0000-0001-6955-7139
Ingrid GarajovàMedical Oncology Unit, University Hospital of Parma, 43100 Parma, Italy.ORCID 0000-0002-9302-6896
Stefania BenattiDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Chiara ChiavelliLaboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, 41121 Modena, Italy.ORCID 0000-0002-1551-7702
Massimo DominiciDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
Fabio GelsominoDepartment of Oncology and Hematology, Division of Oncology, University Hospital of Modena, 41124 Modena, Italy.
University of Modena and Reggio Emilia · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite a recent overall decrease in colorectal cancer (CRC) incidence and mortality, there has been a significant rise in CRC diagnoses in young adults. Early onset colorectal cancer (EOCRC) is defined as CRC diagnosed before the age of 50. Possible predisposing conditions include not only genetic syndromes but also other risk factors, such as microbiome alteration, antibiotic exposure, obesity, diabetes mellitus, and inflammatory bowel disease. EOCRC tends to be diagnosed later than in the older counterpart because of a lack of awareness and the fact that screening for CRC usually starts at the age of 50. Furthermore, CRC in young adults seems to be related to unique molecular features and more aggressive clinical behavior. This paper aims to provide an in-depth review of this poorly understood subject, with a comprehensive review of the state of the art and considerations for future perspectives.

Indexed as

colorectal cancerearly onsetscreening

Identifiers

PMID37444619
PMCPMC10341111
OpenAlexW4383376410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.